Prenatal Metformin Exposure in a Maternal High Fat Diet Mouse Model Alters the Transcriptome and Modifies the Metabolic Responses of the Offspring
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
AIMS: Despite the wide use of metformin in metabolically challenged pregnancies, the long-term effects on the metabolism of the offspring are not known. We studied the long-term effects of prenatal metformin exposure during metabolically challenged pregnancy in mice. MATERIALS AND METHODS: Female mice were on a high fat diet (HFD) prior to and during the gestation. Metformin was administered during gestation from E0.5 to E17.5. Male and female offspring were weaned to a regular diet (RD) and subjected to HFD at adulthood (10-11 weeks). Body weight and several metabolic parameters (e.g. body composition and glucose tolerance) were measured during the study. Microarray and subsequent pathway analyses on the liver and subcutaneous adipose tissue of the male offspring were performed at postnatal day 4 in a separate experiment. RESULTS: Prenatal metformin exposure changed the offspring's response to HFD. Metformin exposed offspring gained less body weight and adipose tissue during the HFD phase. Additionally, prenatal metformin exposure prevented HFD-induced impairment in glucose tolerance. Microarray and annotation analyses revealed metformin-induced changes in several metabolic pathways from which electron transport chain (ETC) was prominently affected both in the neonatal liver and adipose tissue. CONCLUSION: This study shows the beneficial effects of prenatal metformin exposure on the offspring's glucose tolerance and fat mass accumulation during HFD. The transcriptome data obtained at neonatal age indicates major effects on the genes involved in mitochondrial ATP production and adipocyte differentiation suggesting the mechanistic routes to improved metabolic phenotype at adulthood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In one HFD mouse model, administering metformin or placebo orally to a pregnant dam did not influence birth measures.”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, metformin-exposed offspring, when fed a HFD postnatally, had less weight gain and less glucose intolerance than the placebo-exposed offspring.15”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“There is evidence that metformin acts via AMP-activated protein kinase (AMPK) at cellular level [5, 6].”
BackgroundThe hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Spear, B. A., Winick, M., Phillips, C., & Wilfley, D. E. (1975) · Cited by 2,495
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 2×
“Moreover, due to the vast amount of genes detected related to TCA and ETC pathway and based on previously reported effects of metformin on the cellular respiration and ATP production [7, 33], illustrations of metformin targeted genes in the aforementioned pathways are provided in Fig.”
BackgroundMitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · cited 1×
“Previously, the inhibitory effects of metformin on the complex I of the ETC have been reported in a few individual studies [33, 45].”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 1×
“diet, insulin or, as recent studies suggest, with metformin [18, 20].”
ResultDabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277 · cited 1×
“Importantly, it also increases the risk for later metabolic disorders in the offspring [11, 12].”
BackgroundPetrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · cited 1×
“Recent reports have identified a special population of white adipocytes able to transform to a brown-like phenotype under suitable stimuli such as cold exposure, pharmacological b3 -adrenergic stimulation and antidiabetic thiazolidinedione treatment [31, 48–52].”
BackgroundTracking adipogenesis during white adipose tissue development, expansion and regeneration
Wang, Q. A., Tao, C., Gupta, R. K., & Scherer, P. E. (2013) · Nature Medicine · doi:10.1038/nm.3324 · Cited by 1,262
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44271 · Cited by 1,252
Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding
Bouret, S. G., Draper, S. J., & Simerly, R. B. (2004) · Science · doi:10.1126/science.1095004 · Cited by 1,218
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 3×
“Nevertheless, recent data has described that the glucose-lowering effect of metformin may not recruit AMPK in all cases [7] which demonstrate that the knowledge of metformin’s molecular and cellular mechanisms are still incomplete.”
BackgroundMechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · cited 1×
“Its main pharmacological effect in type 2 diabetes is mediated by decreased hepatic gluconeogenesis [1, 2].”
BackgroundBi-directional interconversion of brite and white adipocytes
Rosenwald, M., Perdikari, A., Rülicke, T., & Wolfrum, C. (2013) · Nature Cell Biology · doi:10.1038/ncb2740 · Cited by 800
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Guerra, C., Koza, R. A., Yamashita, H., Walsh, K., & Kozak, L. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3155 · Cited by 635 · cited 1×
“Recent reports have identified a special population of white adipocytes able to transform to a brown-like phenotype under suitable stimuli such as cold exposure, pharmacological b3 -adrenergic stimulation and antidiabetic thiazolidinedione treatment [31, 48–52].”
BackgroundEpigenetic mechanisms that underpin metabolic and cardiovascular diseases
Gluckman, P. D., Hanson, M. A., Buklijas, T., Low, F. M., & Beedle, A. S. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.102 · Cited by 627
Kopecky, J., Clarke, G., Enerbäck, S., Spiegelman, B., & Kozak, L. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118363 · Cited by 553 · cited 1×
“A mouse model of white and brown fat specific Ucp1 expression shows that the induction of Ucp1 together with other mitochondrial genes in white adipose tissue attributes to a lean phenotype [53].”
BackgroundXie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490 · cited 2×
“The dose of metformin was selected according to previous studies [24–29].”
MethodMolecular mechanism of action of metformin: old or new insights?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Diabetologia · doi:10.1007/s00125-013-2991-0 · Cited by 479
Pospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404
Hwang, L., Wang, C., Li, T., Chang, S., Lin, L., Chen, C., Chen, C., Liang, K., Ho, I., Yang, W., et al. (2010) · Obesity · doi:10.1038/oby.2009.273 · Cited by 395
Quantifying Size and Number of Adipocytes in Adipose Tissue
Parlee, S. D., Lentz, S. I., Mori, H., & MacDougald, O. A. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-411619-1.00006-9 · Cited by 389
Role of premature leptin surge in obesity resulting from intrauterine undernutrition
Yura, S., Itoh, H., Sagawa, N., Yamamoto, H., Masuzaki, H., Nakao, K., Kawamura, M., Takemura, M., Kakui, K., Ogawa, Y., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.005 · Cited by 387
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Nutritional programming of the metabolic syndrome
Symonds, M. E., Sebert, S. P., Hyatt, M. A., & Budge, H. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.195 · Cited by 368
Metformin: New Understandings, New Uses
Hundal, R. S., & Inzucchi, S. E. (2003) · Drugs · doi:10.2165/00003495-200363180-00001 · Cited by 308
Maida, A., Lamont, B. J., Cao, X., & Drucker, D. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1937-z · Cited by 294
Morin-Papunen, L., Rantala, A. S., Unkila-Kallio, L., Tiitinen, A., Hippeläinen, M., Perheentupa, A., Tinkanen, H., Bloigu, R., Puukka, K., Ruokonen, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3061 · Cited by 243
Levin, B. E. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1851 · Cited by 221
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Thioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins
Patwari, P., Chutkow, W. A., Cummings, K., Verstraeten, V. L. R. M., Lammerding, J., Schreiter, E. R., & Lee, R. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018093 · Cited by 195
A systematic review on animal models of maternal high fat feeding and offspring glycaemic control
Ainge, H., Thompson, C., Ozanne, S. E., & Rooney, K. B. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.149 · Cited by 188
Metformin in management of pregnant insulin-independent diabetics
Coetzee, E. J., & Jackson, W. P. U. (1979) · Diabetologia · doi:10.1007/bf01221950 · Cited by 178
Wei, E., Ben Ali, Y., Lyon, J., Wang, H., Nelson, R., Dolinsky, V. W., Dyck, J. R. B., Mitchell, G., Korbutt, G. S., & Lehner, R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.005 · Cited by 177
Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T., & Rönnemaa, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12017 · Cited by 174
Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Koenen, T. B., Stienstra, R., van Tits, L. J., de Graaf, J., Stalenhoef, A. F. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2011) · Diabetes · doi:10.2337/db10-0266 · Cited by 172
Fukui, Y., Masui, S., Osada, S., Umesono, K., & Motojima, K. (2000) · Diabetes · doi:10.2337/diabetes.49.5.759 · Cited by 167
High–saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice
Liang, C., Decourcy, K. R., & Prater, M. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.015 · Cited by 156
Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K.-L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1429 · Cited by 134
Cho, N. H., Silverman, B. L., Rizzo, T. A., & Metzger, B. E. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105129 · Cited by 129
Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01466.x · Cited by 101
Metformin for gestational diabetes in routine clinical practice
Goh, J. E. L., Sadler, L., & Rowan, J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03361.x · Cited by 99
Salomäki, H., Vähätalo, L. H., Laurila, K., Jäppinen, N. T., Penttinen, A.-M., Ailanen, L., Ilyasizadeh, J., Pesonen, U., & Koulu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056594 · Cited by 92
Self-citationTertti, K., Ekblad, U., Vahlberg, T., & Rönnemaa, T. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.95 · Cited by 91
Lu, X., Ji, Y., Zhang, L., Zhang, Y., Zhang, S., An, Y., Liu, P., & Zheng, Y. (2012) · Endocrinology · doi:10.1210/en.2012-1151 · Cited by 70
Protective effect of metformin in CD1 mice placed on a high carbohydrate–high fat diet
Hou, M., Venier, N. A., Sugar, L., Musquera, M., Pollak, M., Kiss, A., Fleshner, N. E., Klotz, L. H., & Venkateswaran, V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.152 · Cited by 48
Metformin mitigates the impaired development of skeletal muscle in the offspring of obese mice
Tong, J. F., Yan, X., Zhao, J. X., Zhu, M. J., Nathanielsz, P. W., & Du, M. (2011) · Nutrition & Diabetes · doi:10.1038/nutd.2011.3 · Cited by 40
Cited by
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Chiswick, C., Reynolds, R. M., Denison, F., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S., Wray, S., Weeks, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00219-3 · Cited by 260
Epigenetic effects of metformin: from molecular mechanisms to clinical implications
Bridgeman, S. C., Ellison, G. C., Melton, P. E., Newsholme, P., & Mamotte, C. D. S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13262 · Cited by 190
Metformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 99
Metformin from mother to unborn child-are there unwarranted effects?
Nguyen, L., Chan, S.-Y., & Teo, A. K. K. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.047 · Cited by 67
Metadata
- Authors
- Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M.
- Affiliations
- University of Turku (FI)
- University of Eastern Finland (FI)
- Corresponding author
- Koulu, Markku
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-26
- Volume
- 9
- Issue
- 12
- Pages
- e115778
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4277397
- OpenAlex
- W1997868883
- Cited by
- 63
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 2 · 2018: 13 · 2017: 5 · 2016: 6 · 2015: 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Helsingin Yliopisto
- Kela
- Academy of Finland
- Turun Yliopisto
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- maternal high-fat diet, fat mass accumulation, electron transport chain, mitochondrial ATP production, adipogenesis
- MeSH terms
- Animals, Blood Glucose, Body Weight, Female, Fetus, Glucose Tolerance Test, Lipids, Liver, Male, Metformin, Mice, Inbred C57BL, Pregnancy, Prenatal Exposure Delayed Effects, Adipocytes, Cell Size, Mice, Adipose Tissue, White, Adipokines, Diet, High-Fat, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.